(Q43816068)
Statements
Adenovirus-mediated thymidine kinase gene therapy in combination with topotecan for patients with recurrent ovarian cancer: 2.5-year follow-up (English)
A Hasenburg
X W Tong
D C Fischer
C Nyberg-Hoffman
A L Kaplan
R H Kaufman
I Ramzy
E Aguilar-Cordova